Log in

JULPHAR Gulf Pharmaceutical Industries ADX · United Arab Emirates

Gulf Pharmaceutical Industries (JULPHAR) news

Gulf Pharmaceutical Industries is a public biotech or pharmaceutical company listed on ADX under the ticker JULPHAR, recorded under United Arab Emirates. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Gulf Pharmaceutical Industries news

We have not published a story on Gulf Pharmaceutical Industries yet. When there is news, it will appear here.

Questions about Gulf Pharmaceutical Industries

What is the ticker symbol of Gulf Pharmaceutical Industries?

Gulf Pharmaceutical Industries trades under the ticker JULPHAR on ADX.

Where is Gulf Pharmaceutical Industries listed?

Gulf Pharmaceutical Industries is listed on ADX.

Which country or territory is Gulf Pharmaceutical Industries listed under?

Our directory records Gulf Pharmaceutical Industries under United Arab Emirates.

What does Gulf Pharmaceutical Industries do?

Our directory classifies Gulf Pharmaceutical Industries as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Gulf Pharmaceutical Industries?

The ISIN recorded for Gulf Pharmaceutical Industries is AEG000201018.

Does aibio.space cover Gulf Pharmaceutical Industries?

aibio.space lists Gulf Pharmaceutical Industries among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: Gulf Pharmaceutical Industries

Members talk about Gulf Pharmaceutical Industries (JULPHAR). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open ADX:JULPHAR on TradingView.

Listing details

Gulf Pharmaceutical Industries is a public biotech or pharmaceutical company listed on ADX under the ticker JULPHAR, recorded under United Arab Emirates. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Gulf Pharmaceutical Industries
Ticker
JULPHAR
Listing
ADX
Country or territory
United Arab Emirates
Business scope
Pharmaceuticals: Major
ISIN
AEG000201018
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.